There was an increase in EP3 (PTGER3) and EP4 (PTGER4) receptor gene expression in type I and type II endometrial cancers which could lead to an increase in local PGE2-EP3/EP4 mediated signaling. Here, PTGER4 is linked to endometrial cancer.